ARTICLE | Clinical News
FM-VP4 phytosterol analog: Began Phase I/II trial
October 1, 2001 7:00 AM UTC
Forbes Medi-Tech Inc. (TSE: FMI; FMTI), Vancouver, B.C. Product: FM-VP4 phytosterol analog Business: Nutraceuticals, Cardiovascular Therapeutic category: Metabolic Target: NA Description: Amphipathi...